These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 22639934

  • 21. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E, Egea MA, Souto EB, Calpena AC, García ML.
    Nanotechnology; 2011 Jan 28; 22(4):045101. PubMed ID: 21169662
    [Abstract] [Full Text] [Related]

  • 22. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
    Wang W, Chen L, Huang X, Shao A.
    AAPS PharmSciTech; 2017 Feb 28; 18(2):509-516. PubMed ID: 27120090
    [Abstract] [Full Text] [Related]

  • 23. Nanostructured lipid carriers-based flurbiprofen gel after topical administration: acute skin irritation, pharmacodynamics, and percutaneous absorption mechanism.
    Song A, Su Z, Li S, Han F.
    Drug Dev Ind Pharm; 2015 Feb 28; 41(9):1488-92. PubMed ID: 25231972
    [Abstract] [Full Text] [Related]

  • 24. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.
    Ahmad A, Abuzinadah MF, Alkreathy HM, Banaganapalli B, Mujeeb M.
    PLoS One; 2018 Feb 28; 13(3):e0193451. PubMed ID: 29558494
    [Abstract] [Full Text] [Related]

  • 25. Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers.
    Xu X, Zhao C, Yang H, Jian Y, Zhang Z, Huang Y.
    Drug Deliv; 2011 Feb 28; 18(7):485-92. PubMed ID: 21692681
    [Abstract] [Full Text] [Related]

  • 26. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis.
    Gu Y, Tang X, Yang M, Yang D, Liu J.
    Int J Pharm; 2019 Jan 10; 554():235-244. PubMed ID: 30423415
    [Abstract] [Full Text] [Related]

  • 27. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S, Jain NK, Bedi PM.
    Life Sci; 2013 Nov 13; 93(21):763-72. PubMed ID: 24113071
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil.
    Charoo NA, Shamsher AA, Kohli K, Pillai K, Rahman Z.
    Colloids Surf B Biointerfaces; 2008 Sep 01; 65(2):300-7. PubMed ID: 18579348
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats.
    Bawazeer S, El-Telbany DFA, Al-Sawahli MM, Zayed G, Keed AAA, Abdelaziz AE, Abdel-Naby DH.
    Drug Deliv; 2020 Dec 01; 27(1):1218-1230. PubMed ID: 32772730
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam.
    Khalil RM, Abd-Elbary A, Kassem MA, Ghorab MM, Basha M.
    Pharm Dev Technol; 2014 May 01; 19(3):304-14. PubMed ID: 23528038
    [Abstract] [Full Text] [Related]

  • 36. Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier.
    Kim DW, Kang JH, Oh DH, Yong CS, Choi HG.
    J Microencapsul; 2012 May 01; 29(4):323-30. PubMed ID: 22233141
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S, Ng WK, Tan RB.
    Nanotechnology; 2014 Mar 14; 25(10):105101. PubMed ID: 24531790
    [Abstract] [Full Text] [Related]

  • 40. Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.
    Ali Z, Din FU, Zahid F, Sohail S, Imran B, Khan S, Malik M, Zeb A, Khan GM.
    BMC Pharmacol Toxicol; 2022 Nov 28; 23(1):86. PubMed ID: 36443818
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.